Gohealth, Inc. Stock Price, News & Analysis

GoHealth (NASDAQ: GOCO) reported strong Q1 2025 financial results with notable improvements across key metrics. The company achieved net revenues of $221.0 million, up 19.1% year-over-year, and reduced its net loss to $9.8 million, a 54.2% improvement from the previous year. Adjusted EBITDA grew 56.4% to $42.1 million. Operational metrics showed significant progress with Submissions increasing 40.2% to 303,026, while Direct Operating Cost per Submission improved 18.4% to $522. The company also launched GoHealth Protect, expanding into guaranteed acceptance life insurance to diversify product offerings and enhance customer relationships. Management emphasized their focus on platform refinement, technology improvements, and strategic investments to drive better business outcomes and consumer experience.

GoHealth (NASDAQ: GOCO) has issued a firm denial of allegations in a United States False Claims Act lawsuit regarding events from 2016 to 2021. The company, a leading health insurance marketplace and Medicare-focused digital health firm, refutes claims of receiving kickbacks or placing beneficiaries in suboptimal plans. GoHealth emphasizes its strong track record in serving special needs beneficiaries, who represent 35% of GoHealth enrollees compared to 17% of the general Medicare Advantage population. The company highlights its initiatives like the Low Income Subsidy team and PlanFit program, which focus on beneficiary needs without financial benefit to GoHealth. The company plans to vigorously defend itself while maintaining its mission to provide customers with healthcare decision support.

GoHealth (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, has scheduled its first quarter 2025 financial results announcement for May 13, 2025. The results will be released in the morning, followed by a conference call and live audio webcast at 8:00 a.m. ET. CEO Vijay Kotte and CFO Brendan Shanahan will host the event, which will be accessible through GoHealth's Investor Relations website. An on-demand replay of the call will be made available shortly after the event concludes.

GoHealth Inc. (NASDAQ: GOCO) demonstrated robust performance in Q4 2024, with net revenues climbing 41% year-over-year to $389.1 million. The company's success was driven by a significant 67% increase in submissions, while achieving operational efficiencies with a 27% improvement in Direct Operating Cost per Submission to $501.

The Medicare-focused digital health marketplace provider reported a remarkable turnaround, posting a net income of $58.0 million, compared to a loss in the previous year. Additionally, the company's Adjusted EBITDA more than doubled to $117.8 million, reflecting successful strategic investments in technology and operational excellence.

GoHealth (NASDAQ: GOCO) reported strong Q4 2024 results with net revenues of $389.1 million, up 41% year-over-year. The company achieved significant growth with 481,445 submissions, a 67% increase from the previous year.

Q4 highlights include net income of $58.0 million, improving by $60.3 million, and Adjusted EBITDA of $117.8 million, up 107%. Direct Operating Cost per Submission improved 27% to $501.

Full-year 2024 performance showed net revenues of $798.9 million (9% growth), with 1,016,182 submissions (23% increase). The company reduced its net loss to $7.3 million, a $144.0 million improvement. Key achievements include successful refinancing of credit facility, implementation of PlanFit Save initiative, and supporting nearly 3 million Medicare consumers.

GoHealth (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, has scheduled its fourth quarter 2024 financial results announcement for February 27, 2025. The results will be released in the morning, followed by a conference call and live audio webcast at 8:00 a.m. ET.

CEO Vijay Kotte and CFO Brendan Shanahan will host the call to discuss the results. Investors can access the webcast through GoHealth's Investor Relations website, with a replay available on-demand after the call's completion.

GoHealth (NASDAQ: GOCO) has announced its participation in the upcoming Southwest IDEAS Conference in Dallas, TX. CEO Vijay Kotte will deliver a presentation on Wednesday, November 20th, 2024, at 1:20 PM CT at The Statler Dallas. The event will be accessible to virtual attendees through a webcast, with registration available online.

GoHealth announces its commitment to assist 25,000 veterans in finding suitable health plans during this year's Medicare Annual Enrollment Period (AEP). The company highlights the case of Air Force veteran Paul Docka, who, along with his wife Mary, received assistance from GoHealth agent Dalynn Garfield in navigating plan changes affecting their dental coverage.

The announcement comes amid unprecedented disruption in Medicare Advantage plans, with an estimated 6 million beneficiaries facing plan degradation and 2 million affected by plan exits. GoHealth CEO Vijay Kotte emphasizes the importance of beneficiaries exploring all options before the AEP deadline on December 7.

GoHealth (NASDAQ: GOCO) reported its third-quarter 2024 results with net revenues of $118.3 million, down $13.7 million from the previous year. Despite this, Submissions increased by 2.9% to 166,195. The company saw a net income of $15.4 million, a significant improvement from a $56.2 million loss the prior year. However, Adjusted EBITDA was negative $12.1 million, slightly worse than last year's negative $11.5 million. The trailing twelve months' cash flow from operations turned positive at $35.1 million. GoHealth completed the acquisition of e-TeleQuote, adding $90.5 million in contract assets and $22.5 million in cash, and achieving a $77.4 million gain on bargain purchase. The company also reduced its Direct Operating Cost per Submission by 11.0% and appointed Brendan Shanahan as CFO. GoHealth aims to capitalize on the Medicare Annual Enrollment Period with an expanded agent network and AI-driven technology.